Lung Cancer
LifeBit to Store, Manage Data For Lung Cancer Genetics Study
Non-profit research institutions will be able to access data from the 23andMe-sponsored study via a Lifebit data platform.
The retrospective results suggest that the test's sensitivity boost over other platforms can overcome the challenge of detecting ctDNA in adenocarcinomas.
African, Asian Ancestry Patients Less Likely to Be Eligible for New Precision Oncology Drugs
Premium
A new study found that fewer African and Asian patients had clinically actionable alterations for lung, breast, and colorectal cancer.
TRACERx Lung Cancer Study Validates Prognostic Clonal Gene Expression Test
TRACERx researchers studied the 23-transcript ORACLE clonal expression biomarker, prospectively linking ORACLE risk classification to lung adenocarcinoma survival.
Biodesix Preliminary Revenues up 39 Percent for Q4, 45 Percent for 2024
The company projected that it grew its revenues by double digits in both diagnostic testing and biopharma and other services.